Liquid biopsy to tailor the treatment of advanced hormone receptor-positive breast cancer in the era of novel endocrine agents and CDK4/6-inhibitors.

ABSTRACT:

SUBMITTER: Segui E 

PROVIDER: S-EPMC10777248 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature